|
TH1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75230052690267E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26969999958426E-07 |
| Normal-vs-Stage2 |
2.7964000000047E-06 |
| Normal-vs-Stage3 |
2.88190005193201E-09 |
| Normal-vs-Stage4 |
1.818180E-04 |
| Stage1-vs-Stage2 |
1.824560E-01 |
| Stage1-vs-Stage3 |
3.747800E-02 |
| Stage1-vs-Stage4 |
6.577600E-01 |
| Stage2-vs-Stage3 |
8.125200E-01 |
| Stage2-vs-Stage4 |
5.141200E-01 |
| Stage3-vs-Stage4 |
3.043800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47679979356496E-10 |
| Normal-vs-AfricanAmerican |
8.13929999999852E-05 |
| Normal-vs-Asian |
2.952400E-01 |
| Caucasian-vs-AfricanAmerican |
9.152600E-01 |
| Caucasian-vs-Asian |
3.267200E-01 |
| AfricanAmerican-vs-Asian |
3.089000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.08879613395175E-11 |
| Normal-vs-Female |
1.34829999998143E-06 |
| Male-vs-Female |
1.384850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.339600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.93969999851396E-08 |
| Normal-vs-Age(61-80Yrs) |
1.27230004309808E-09 |
| Normal-vs-Age(81-100Yrs) |
5.063600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.619800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.464000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.809800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.170400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.404200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.901600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.053000E-01 |
| Normal-vs-Grade 2 |
3.52459999997112E-06 |
| Normal-vs-Grade 3 |
2.29270002982673E-09 |
| Normal-vs-Grade 4 |
8.55709947344963E-10 |
| Grade 1-vs-Grade 2 |
3.258000E-01 |
| Grade 1-vs-Grade 3 |
1.097160E-01 |
| Grade 1-vs-Grade 4 |
1.452080E-02 |
| Grade 2-vs-Grade 3 |
9.752200E-02 |
| Grade 2-vs-Grade 4 |
1.736460E-03 |
| Grade 3-vs-Grade 4 |
4.849900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.639600E-04 |
| Normal-vs-ccB subtype |
2.02060590481778E-14 |
| ccA subtype-vs-ccB subtype |
1.45110000016047E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.08800000015097E-08 |
| Normal-vs-N1 |
4.271900E-02 |
| N0-vs-N1 |
6.273000E-01 |
|
|
